Zacks Rank & Key Picks
Kamada currently carries a Zacks Rank #3 (Hold). Better-ranked stocks in healthcare sector are Bayer AG BAYRY and Regeneron Pharmaceuticals, Inc. REGN. Each stock sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today's Zacks #1 Rank stocks here.
Regeneron's earnings per share estimates inched up from $10.16 to $10.52 for 2017 and from $10.90 to $12.10, over the last 60 days. The company posted positive earnings surprises in two of the four trailing quarters with an average beat of 0.45%.
Bayer's earnings per share estimates increased from $8.75 to $8.86 for 2017 and from $9.41 to $9.53 for 2018, over the last 30 days. The company posted positive earnings surprises in three of the four trailing quarters with an average beat of 10.25%.
The Best & Worst of Zacks
Today you are invited to download the full, up-to-the-minute list of 220 Zacks Rank #1 "Strong Buys" free of charge. From 1988 through 2015 this list has averaged a stellar gain of +25% per year. Plus, you may download 220 Zacks Rank #5 "Strong Sells." Even though this list holds many stocks that seem to be solid, it has historically performed 6X worse than the market. See these critical buys and sells free >>
Bayer AG (BAYRY): Free Stock Analysis Report
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN
Kamada Ltd. (NASDAQ:KMDA
Shire PLC (NASDAQ:SHPG
To read this article on Zacks.com click here.
Zacks Investment Research
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
